|
Sign In to gain access to subscriptions and/or personal tools.
|
Probabilistic Sensitivity Analysis for Decision Trees with Multiple Branches: Use of the Dirichlet Distribution in a Bayesian Framework
Andrew H. Briggs, DPhil
Health Economics Research Centre, University of Oxford, Oxford, United Kingdom, andrew.briggs{at}ihs.ox.ac.uk
A. E. Ades, PhD
Medical Re- search Council, Health Services Research Collaboration, University of Bristol, Bristol, United Kingdom
Martin J. Price, PhD
Janssen-Cilag Ltd., United Kingdom
In structuring decision models of medical interventions, it is commonly recommended that only 2 branches be used for each chance node to avoid logical inconsistencies that can arise during sensitivity analyses if the branching probabilities do not sum to 1. However, information may be naturally available in an unconditional form, and structuring a tree in conditional form may complicate rather than simplify the sensitivity analysis of the unconditional probabilities. Cur- rent guidance emphasizes using probabilistic sensitivity analysis, and a method is required to provide probabilistic probabilities over multiple branches that appropriately rep- resents uncertainty while satisfying the requirement that mutually exclusive event probabilities should sum to 1. The authors argue that the Dirichlet distribution, the multivariate equivalent of the beta distribution, is appropriate for this purpose and illustrate its use for generating a fully probabilistic transition matrix for a Markov model. Furthermore, they demonstrate that by adopting a Bayesian approach, the problem of observing zero counts for transitions of interest can be overcome.
Key Words: probabilistic sensitivity analysis decision models Dirichlet distribution
Medical Decision Making, Vol. 23, No. 4,
341-350 (2003)
DOI: 10.1177/0272989X03255922

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C E Gartner, J J Barendregt, and W D Hall
Predicting the future prevalence of cigarette smoking in Australia: how low can we go and by when?
Tob. Control,
June 1, 2009;
18(3):
183 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brennan, S. Kharroubi, A. O'Hagan, and J. Chilcott
Calculating Partial Expected Value of Perfect Information via Monte Carlo Sampling Algorithms
Med Decis Making,
August 1, 2007;
27(4):
448 - 470.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Smith, A. E. Barnato, and M. S. Roberts
Teaching Medical Decision Modeling: A Qualitative Description of Student Errors and Curriculum Responses
Med Decis Making,
November 1, 2006;
26(6):
583 - 588.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Regier, R. Sunderji, L. D. Lynd, K. Gin, and C. A. Marra
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.
Can. Med. Assoc. J.,
June 20, 2006;
174(13):
1847 - 1852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hudry, J. O Rinne, T. Keranen, L. Eckert, and J. M Cochran
Cost-Utility Model of Rasagiline in the Treatment of Advanced Parkinson's Disease in Finland
Ann. Pharmacother.,
April 1, 2006;
40(4):
651 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. M. Hunink
Decision Making in the Face of Uncertainty and Resource Constraints: Examples from Trauma Imaging
Radiology,
May 1, 2005;
235(2):
375 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. T. Shih, S. Han, and S. B. Cantor
Impact of Generic Drug Entry on Cost-Effectiveness Analysis
Med Decis Making,
January 1, 2005;
25(1):
71 - 80.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton
A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention
Med Decis Making,
November 1, 2004;
24(6):
634 - 653.
[Abstract]
[PDF]
|
 |
|
|
|